Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Prezioso

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|January 1, 1997
[The UroLink project: objectives and general data]D Prezioso
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 1, 1996
[Mepartricin in BPH. A new dosage approach]D Prezioso, F Fabrizio, A Russo, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 1, 1996
[Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy]D Prezioso, V Mirone, F Fabrizio, et al.
European Urology|March 19, 1999
Role of neoadjuvant treatment in clinically confined prostate cancer. Takeda NHT Italian GroupD Prezioso, T Lotti, R Montironi, et al.
Minerva Medica|April 1, 1996
[Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial]V Mirone, D Prezioso, A Palmieri, et al.
European Urology|January 1, 1984
Mucinous adenocarcinoma of the renal pelvisV Mirone, D Prezioso, S Palombini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 9, 2006
[Antibacterial prophylaxis in endourological procedures]D Prezioso, R Bartoletti, R Damiano, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1988
[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy]V Mirone, D Prezioso, A Palmieri, et al.
Urologia Internationalis|June 2, 1998
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian GroupD Prezioso, T Lotti, R Montironi, et al.
Journal D'Urologie|January 1, 1995
Benign prostatic hyperplasia (BPH) and sexualityT Lotti, V Mirone, C Imbimbo, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|January 1, 1997
[The UroLink project: objectives and general data]D Prezioso
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 1, 1996
[Mepartricin in BPH. A new dosage approach]D Prezioso, F Fabrizio, A Russo, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 1, 1996
[Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy]D Prezioso, V Mirone, F Fabrizio, et al.
European Urology|March 19, 1999
Role of neoadjuvant treatment in clinically confined prostate cancer. Takeda NHT Italian GroupD Prezioso, T Lotti, R Montironi, et al.
Minerva Medica|April 1, 1996
[Mepartricin 150.000 (40 mg) vs mepartricin 50.000 U (13 mg) in the treatment of BIP. Double blind clinical trial]V Mirone, D Prezioso, A Palmieri, et al.
European Urology|January 1, 1984
Mucinous adenocarcinoma of the renal pelvisV Mirone, D Prezioso, S Palombini, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|June 9, 2006
[Antibacterial prophylaxis in endourological procedures]D Prezioso, R Bartoletti, R Damiano, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 1, 1988
[Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy]V Mirone, D Prezioso, A Palmieri, et al.
Urologia Internationalis|June 2, 1998
Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer. Takeda NHT Italian GroupD Prezioso, T Lotti, R Montironi, et al.
Journal D'Urologie|January 1, 1995
Benign prostatic hyperplasia (BPH) and sexualityT Lotti, V Mirone, C Imbimbo, et al.
Pageof 3